Cardiology
Conference Coverage
Treatment guided by remote readings works when used as intended
PHILADELPHIA –
FDA/CDC
FDA adds diabetic kidney disease, heart failure indications to canagliflozin
This marks the first time in 20 years that a drug has been indicated for diabetic kidney disease treatment, according to the manufacturer.
Conference Coverage
Cardiotoxicity after checkpoint inhibitor treatment seen early, linked to elevated biomarkers
PHILADELPHIA – The findings support monitoring of cardiac biomarkers in the initial phase of checkpoint inhibitor treatment to identify patients...
Conference Coverage
Machine learning–derived risk score predicts heart failure risk in diabetes patients
Highest WATCH-DM scores linked to 5-year heart failure risk approaching 20%.
News
Early infusion of mononuclear cells may benefit stroke patients
Well-designed RCTs are needed to further assess safety and efficacy of the approach.
News
Daily polypill lowers BP, cholesterol in underserved population
The regimen’s simplicity and low cost may overcome barriers to treatment, such as lack of income, underinsurance, and difficulty attending clinic...
News
Drug abuse–linked infective endocarditis spiking in U.S.
New cases doubled from 2002 to 2016, and those affected tended to be younger white males living in poverty.
Latest News
Milrinone beats dobutamine in extending survival in HF
PHILADELPHIA – Survival benefit favored milrinone regardless of indication for use in continuous outpatient intravenous inotropic therapy.
Conference Coverage
European cholesterol guidelines push LDL targets below 55 mg/dL
PARIS –
Conference Coverage
BP load predicts cardiovascular damage in children
NEW ORLEANS – The amount of time spent above the 95th blood pressure percentile is an emerging metric of pediatric hypertension control.